1. Home
  2. THRY vs ENLV Comparison

THRY vs ENLV Comparison

Compare THRY & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$4.26

Market Cap

170.3M

Sector

Industrials

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$2.33

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
ENLV
Founded
2012
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
149.0M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
THRY
ENLV
Price
$4.26
$2.33
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$9.33
$20.00
AVG Volume (30 Days)
451.8K
253.1K
Earning Date
04-30-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$41.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$0.43
52 Week High
$14.28
$7.64

Technical Indicators

Market Signals
Indicator
THRY
ENLV
Relative Strength Index (RSI) 58.68 41.82
Support Level $3.27 $0.79
Resistance Level $4.44 $7.64
Average True Range (ATR) 0.26 0.67
MACD -0.00 -0.28
Stochastic Oscillator 89.24 0.37

Price Performance

Historical Comparison
THRY
ENLV

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: